Resultados da pesquisa por Autor :: UTM Library Massive Scholar Tracking

1

Target engagement: shining a light Por Huber, K

Publicado em 2017

Journal article
2

Mapping the chemical chromatin reactivation landscape identifies BRD4-TAF1 cross-talk Por Huber, K, Knapp, S, Fedorov, O

Publicado em 2016

Journal article
3

PIM serine/threonine kinases in the pathogenesis and therapy of hematologic malignancies and solid cancers. Por Brault, L, Gasser, C, Bracher, F, Huber, K, Knapp, S, Schwaller, J

Publicado em 2010

Journal article
4

KH-TFMDI, a novel sirtuin inhibitor, alters the cytoskeleton and mitochondrial metabolism promoting cell death in Leishmania amazonensis Por Verçoza, B, Godinho, J, de Macedo-Silva, S, Huber, K, Bracher, F, de Souza, W, Rodrigues, J

Publicado em 2017

Journal article
5

Alterations on growth and cell organization of Giardia intestinalis trophozoites after treatment with KH-TFMDI, a novel class III histone deacetylase inhibitor Por Gadelha, A, Bravim, B, Vidal, J, Reignault, L, Cosme, B, Huber, K, Bracher, F, De Souza, W

Publicado em 2019

Journal article
6

Chemical instability and promiscuity of arylmethylidenepyrazolinone-based MDMX inhibitors Por Stefaniak, J, Lewis, A, Conole, D, Galan, S, Bataille, C, Wynne, G, Castaldi, M, Lundbäck, T, Russell, A, Huber, K

Publicado em 2018

Journal article
7

Lapatinib potentiates cytotoxicity of YM155 in neuroblastoma via inhibition of the ABCB1 efflux transporter Por Radic-Sarikas, B, Halasz, M, Huber, K, Winter, G, Tsafou, K, Papamarkou, T, Brunak, S, Kolch, W, Superti-Furga, G

Publicado em 2017

Journal article
8

Adhesion molecule expression and cell cycle control in cells of the immune system are sensitive to altered gravity Por Kroll H, Zipp F, von der Wiesche M, Hemmersbach R, Huber K, Paulsen K, Thiel C, Ullrich O, Engelmann F

Publicado em 2009-02-01

Artigo
9

Quantifying target occupancy of small molecules within living cells Por Robers, MB, Friedman-Ohana, R, Huber, K, Kilpatrick, L, Vasta, JD, Berger, B-T, Chaudhry, C, Hill, S, Müller, S, Knapp, S, Wood, KV

Publicado em 2020

Journal article
10

Composition and seasonality of Culicoides in three host environments in Rabat region (Morocco) Por Bourquia, M, Garros, C, Rakotoarivony, I, Boukhari, I, Chakrani, M, Huber, K, Gardès, L, Wint, W, Baldet, T, Khallaayoune, K, Balenghien, T

Publicado em 2020

Journal article
11

Re-evaluating the mechanism of action of α,β-unsaturated carbonyl DUB inhibitors B-AP15 and VLX1570: a paradigmatic example of unspecific protein crosslinking with Michael acceptor... Por Ward, J, Pinto-Fernandez, A, Cornelissen, L, Bonham, S, Diaz Saez, L, Riant, O, Huber, K, Kessler, B, Feron, O, Tate, E

Publicado em 2019

Working paper
12

7,8-dichloro-1-oxo-β-carbolines as a versatile scaffold for the development of potent and selective kinase inhibitors with unusual binding modes. Por Huber, K, Brault, L, Fedorov, O, Gasser, C, Filippakopoulos, P, Bullock, A, Fabbro, D, Trappe, J, Schwaller, J, Knapp, S, Bracher, F

Publicado em 2012

Journal article
13

Combinatorial drug screening identifies Ewing sarcoma-specific sensitivities Por Radic-Sarikas, B, Tsafou, K, Emdal, K, Papamarkou, T, Huber, K, Mutz, C, Toretsky, J, Bennett, K, Olsen, J, Brunak, S, Kovar, H, Superti-Furga, G

Publicado em 2016

Journal article
14

Specific CLK inhibitors from a novel chemotype for regulation of alternative splicing. Por Fedorov, O, Huber, K, Eisenreich, A, Filippakopoulos, P, King, O, Bullock, A, Szklarczyk, D, Jensen, L, Fabbro, D, Trappe, J, Rauch, U, Bracher, F, Knapp, S

Publicado em 2011

Journal article
15

Specific CLK inhibitors from a novel chemotype for regulation of alternative splicing. Por Fedorov, O, Huber, K, Eisenreich, A, Filippakopoulos, P, King, O, Bullock, A, Szklarczyk, D, Jensen, L, Fabbro, D, Trappe, J, Rauch, U, Bracher, F, Knapp, S

Publicado em 2011

Journal article
16

Thiazolidine derivatives as potent and selective inhibitors of the PIM kinase family. Por Bataille, C, Brennan, M, Byrne, S, Davies, S, Durbin, M, Fedorov, O, Huber, K, Jones, A, Knapp, S, Liu, G, Nadali, A, Quevedo, C, Russell, A, Walker, R, Westwood, R, Wynne, G

Publicado em 2017

Journal article
17

General mechanisms of coagulation and targets of anticoagulants (Section I). Position Paper of the ESC Working Group on Thrombosis--Task Force on Anticoagulants in Heart Disease. Por De Caterina, R, Husted, S, Wallentin, L, Andreotti, F, Arnesen, H, Bachmann, F, Baigent, C, Huber, K, Jespersen, J, Kristensen, S, Lip, G, Morais, J, Rasmussen, L, Siegbahn, A, Verheugt, F, Weitz, J

Publicado em 2013

Journal article
18

Parenteral anticoagulants in heart disease: current status and perspectives (Section II). Position paper of the ESC Working Group on Thrombosis-Task Force on Anticoagulants in Hear... Por De Caterina, R, Husted, S, Wallentin, L, Andreotti, F, Arnesen, H, Bachmann, F, Baigent, C, Huber, K, Jespersen, J, Kristensen, S, Lip, G, Morais, J, Rasmussen, L, Siegbahn, A, Verheugt, F, Weitz, J

Publicado em 2013

Journal article
19

New oral anticoagulants in atrial fibrillation and acute coronary syndromes: ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease position paper. Por De Caterina, R, Husted, S, Wallentin, L, Andreotti, F, Arnesen, H, Bachmann, F, Baigent, C, Huber, K, Jespersen, J, Kristensen, S, Lip, G, Morais, J, Rasmussen, L, Siegbahn, A, Verheugt, F, Weitz, J

Publicado em 2012

Journal article
20

Vitamin K antagonists in heart disease: current status and perspectives (Section III). Position paper of the ESC Working Group on Thrombosis--Task Force on Anticoagulants in Heart... Por De Caterina, R, Husted, S, Wallentin, L, Andreotti, F, Arnesen, H, Bachmann, F, Baigent, C, Huber, K, Jespersen, J, Kristensen, S, Lip, G, Morais, J, Rasmussen, L, Siegbahn, A, Verheugt, F, Weitz, J

Publicado em 2013

Journal article